)
CeriBell (CBLL) investor relations material
CeriBell 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business Overview and Market Opportunity
Developed an AI-powered neuromonitoring platform with easy-to-use hardware and the Clarity algorithm, targeting seizure detection in acute care and a $3.5B+ U.S. market, including adult, pediatric, and delirium segments.
Achieved $87M–$89M in 2025 revenue, 34% YoY growth, and 88% gross margin as of Q3 2025.
Recurring revenue model: ~25% from SaaS/subscription, ~75% from single-use disposables, with consistent quarterly growth.
Only 3% of the addressable market and 10% of hospitals penetrated as of September 2025, with 600+ hospitals onboarded.
Top customers use 3x more devices than average, indicating strong potential for deeper account utilization.
Clinical Need, Impact, and Technology Differentiation
Seizures are highly prevalent and often undiagnosed in critically ill patients; up to 92% of ICU seizures are non-convulsive and require EEG for diagnosis.
Clarity algorithm enables rapid, continuous EEG monitoring and real-time seizure detection, reducing time to treatment and supporting earlier intervention.
Studies show Ceribell reduces ICU stay by 4.1 days, door-to-EEG time by 19.4 hours, and severe disability at discharge by 18 percentage points.
First and only FDA-cleared seizure detection for preterm and pediatric populations, and delirium detection.
Published nearly 50 studies and 100 abstracts supporting clinical efficacy.
Growth Strategy and Market Expansion
2026 focus: drive account acquisition, expand utilization in existing accounts, and leverage expanded sales force.
Gained FedRAMP High certification, unlocking access to 160 VA hospitals and expanding into children's hospitals.
FDA clearance for neonate and pediatric seizure detection adds $400M TAM and access to 280 children's hospitals, with full launch planned for 2026.
Commercial pilot and full launch of delirium detection planned for late 2026/early 2027, with further TAM expansion.
Plans to expand into NICU, PICU, and integrate into more hospital protocols and departments.
Next CeriBell earnings date
Next CeriBell earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)